|
MDK-4154 (HDAC inhibitor IV)
- 品牌：MedKoo
- 產(chǎn)地：美國
- 貨號：406734
- cas：537034-15-4
- 發(fā)布日期： 2022-07-20
- 更新日期： 2024-08-12
產(chǎn)品詳請
| 產(chǎn)地 | 美國 |
| 品牌 | MedKoo |
| 貨號 | 406734 |
| 用途 | This product is for research use only, not for human or veterinary use. |
| 包裝規(guī)格 | 100.0mg; 200.0mg; 500.0mg; 1.0g; 2.0g; 5.0g; |
| CAS編號 | 537034-15-4 |
| 純度 | >98%% |
| 是否進(jìn)口 | 是 |
中文名稱:PAOA
中文別名:N-(2-氨基苯基)-n-苯基庚烷二酰胺
CAS No:537034-15-4
分子式:C19H23N3O2
沸點:627.86°C at 760 mmHg
閃光點:333.518°C
折射率:1.644
密度:1.213
用途:1、Histone deacetylase inhibitor IV. A cell-permeable pimeloylanilide compound that acts as a FXN-(frataxin gene) specific HDAC inhibitor. Reverses the silencing of FXN transcription in FRDA (Friedrich鈥檚 ataxia) cells due to hypoacetylation of histones H3 and H4.
中文別名:N-(2-氨基苯基)-n-苯基庚烷二酰胺
CAS No:537034-15-4
分子式:C19H23N3O2
沸點:627.86°C at 760 mmHg
閃光點:333.518°C
折射率:1.644
密度:1.213
用途:1、Histone deacetylase inhibitor IV. A cell-permeable pimeloylanilide compound that acts as a FXN-(frataxin gene) specific HDAC inhibitor. Reverses the silencing of FXN transcription in FRDA (Friedrich鈥檚 ataxia) cells due to hypoacetylation of histones H3 and H4.
相關(guān)產(chǎn)品：
